Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for AMPLI from our risk checks.
Amplitude Surgical SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €3.22 |
52 Week High | €3.68 |
52 Week Low | €2.70 |
Beta | 0.52 |
11 Month Change | 2.55% |
3 Month Change | 10.27% |
1 Year Change | -6.40% |
33 Year Change | 52.61% |
5 Year Change | 144.87% |
Change since IPO | -35.60% |
Recent News & Updates
Shareholder Returns
AMPLI | FR Medical Equipment | FR Market | |
---|---|---|---|
7D | 2.5% | -0.1% | 0.5% |
1Y | -6.4% | 21.3% | 1.3% |
Return vs Industry: AMPLI underperformed the French Medical Equipment industry which returned 21.9% over the past year.
Return vs Market: AMPLI underperformed the French Market which returned 1% over the past year.
Price Volatility
AMPLI volatility | |
---|---|
AMPLI Average Weekly Movement | 4.6% |
Medical Equipment Industry Average Movement | 5.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in FR Market | 9.6% |
10% least volatile stocks in FR Market | 2.6% |
Stable Share Price: AMPLI has not had significant price volatility in the past 3 months.
Volatility Over Time: AMPLI's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 416 | Olivier Jallabert | www.amplitude-surgical.com |
Amplitude Surgical SA develops and markets products for orthopedic surgery. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.
Amplitude Surgical SA Fundamentals Summary
AMPLI fundamental statistics | |
---|---|
Market cap | €154.52m |
Earnings (TTM) | -€2.98m |
Revenue (TTM) | €104.05m |
1.5x
P/S Ratio-51.8x
P/E RatioIs AMPLI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AMPLI income statement (TTM) | |
---|---|
Revenue | €104.05m |
Cost of Revenue | €51.68m |
Gross Profit | €52.37m |
Other Expenses | €55.35m |
Earnings | -€2.98m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Oct 23, 2024
Earnings per share (EPS) | -0.062 |
Gross Margin | 50.33% |
Net Profit Margin | -2.87% |
Debt/Equity Ratio | 108.4% |
How did AMPLI perform over the long term?
See historical performance and comparison